ICU Medical swings to Q3 net profit of $26.85 million
ICUI•ICU Medical reported third-quarter 2026 GAAP net income of $26.85 million, compared with a loss a year earlier, and revenue of $560.44 million. It maintained fiscal 2026 GAAP net income guidance of $73 million to $83 million and expects results toward the high end.
1. Quarterly results
ICU Medical swung to third-quarter 2026 GAAP net income of $26.85 million from a year-earlier loss, while revenue rose to $560.44 million. CEO Vivek Jain said Infusion Systems exceeded third-quarter expectations and the rest of the business generally met expectations.
2. Full-year outlook
The company maintained fiscal 2026 GAAP net income guidance of $73 million to $83 million and expects results toward the range’s high end.
